Evidence
ACS Pharmacol Transl Sci. 2023 Mar 6;6(4):519-525. doi: 10.1021/acsptsci.2c00230. eCollection 2023 Apr 14.
ABSTRACT
Despite an increasing prevalence of gabapentinoids (gabapentin and pregabalin) in opioid overdose deaths, little research has evaluated potentially harmful interactions between gabapentinoids and opioids. This study sought to determine the effects of gabapentinoids on the ventilatory depressive effects of heroin and their reversal by naloxone. Rats were given gabapentin, pregabalin, or saline prior to receiving increasing doses of heroin while ventilation was monitored using whole-body plethysmography. In some sessions naloxone was administered following the largest dose of heroin. The primary outcomes of this study were minute volume and Pause. Heroin dose-dependently reduced minute volume and increased Pause. Administration of naloxone dose-dependently reversed the effects of heroin on ventilation. Gabapentinoids did not alter the ventilatory depressive effects of heroin alone but reduced the potency of naloxone to reverse heroin-induced ventilatory depression. These preliminary findings emphasize the need for further research evaluating interactions between gabapentinoids and opioids related to substance misuse and overdose.
PMID:37082751 | PMC:PMC10111619 | DOI:10.1021/acsptsci.2c00230
Estimated reading time: 3 minute(s)
Latest: Psychiatryai.com #RAISR4D
Cool Evidence: Engaging Young People and Students in Real-World Evidence
Real-Time Evidence Search [Psychiatry]
AI Research
Effects of Gabapentinoids on Heroin-Induced Ventilatory Depression and Reversal by Naloxone
🌐 90 Days
VR Related Evidence Matrix
- Fact vs. fiction: naloxone in the treatment of opioid-induced respiratory depression in the current era of synthetic opioids
- Exploring racial and secondary substance use differences in route of administration of opioid drugs: Analysis of the 2015-2019 treatment admission data
- Exploring racial and secondary substance use differences in route of administration of opioid drugs: Analysis of the 2015-2019 treatment admission data
- Blood pressure response to extended-release naltrexone in heroin and prescription opioid users and its implications for cardiovascular morbidity
- National Institute on Drug Abuse Clinical Trials Network Meeting Report: Managing Patients Exposed to Xylazine-Adulterated Opioids in Emergency, Hospital and Addiction Care Settings
- The sociodemographic profile and the challenges associated with treatment and rehabilitation in female heroin users: A case series from Northeast India
- Antineuropathic Pain Management After Orthopedic Surgery: A Systematic Review
- Take-Home Naloxone Access and Use among Older Adults Living with Pain: A Scoping Review
- Genome-wide association study reveals multiple loci for analgesia and opioid consumption behaviors associated with heroin vulnerability in outbred rats
- Stocking and supplying naloxone: Findings from a representative sample of community pharmacies in Victoria, Australia
- Prescription Opioid Dose Change Prior to Fatal Opioid-Detected Overdose
- µ-Opioid receptor antagonism facilitates the anxiolytic-like effect of oxytocin in mice
- The association between naloxone claims and proportion of independent vs. chain pharmacies: A longitudinal analysis of naloxone claims in the US
- Implementation Documentation and Process Assessment of the PharmNet Intervention: Observational Report
- NCP, a dual kappa and mu opioid receptor agonist, is a potent analgesic against inflammatory pain without reinforcing or aversive properties
- Prescribing practices in opioid agonist treatment and changes in compliance to clinical dosing guidelines in British Columbia, Canada
- Overdose from Unintentional Fentanyl Use when Intending to Use a Non-opioid Substance: An Analysis of Medically Attended Opioid Overdose Events
- Substance use patterns, sociodemographics, and health profiles of harm reduction service recipients in Burlington, Vermont
- Model of negative affect induced by withdrawal from acute and chronic morphine administration in male mice
- Prediction of naloxone dose in opioids toxicity based on machine learning techniques (artificial intelligence)
- Prediction of naloxone dose in opioids toxicity based on machine learning techniques (artificial intelligence)
- Building bridges to outpatient treatment services for post-overdose care via paramedic buprenorphine field initiation
- Building bridges to outpatient treatment services for post-overdose care via paramedic buprenorphine field initiation
- Multimodal Acute Pain Management in the Parturient with Opioid Use Disorder: A Review
- Broad evidence of xylazine in the UK illicit drug market beyond heroin supplies: Triangulating from toxicology, drug-testing and law enforcement
- The fentanyl-specific antibody FenAb024 can shield against carfentanil effects
- Evaluation of heroin-assisted treatment in Norway: protocol for a mixed methods study
- Psychedelic Therapy: A Primer for Primary Care Clinicians-Ibogaine
- Characterising methamphetamine/amphetamine use among opioid agonist therapy-seeking adults with prescription-type opioid use disorder in Canada
- Characterising methamphetamine/amphetamine use among opioid agonist therapy-seeking adults with prescription-type opioid use disorder in Canada
- Clinical and neuroradiographic features of fentanyl inhalation-induced leukoencephalopathy
- Exploring the potential use of melatonin as a modulator of tramadol-induced rewarding effects in rats
- Protein Corona Composition of Gold Nanocatalysts
- Xylazine: A Drug Adulterant of Clinical Concern
- Pilot RCT comparing low-dose naltrexone, gabapentin and placebo to reduce pain among people with HIV with alcohol problems
- Higher First 30-Day Dose of Buprenorphine for Opioid Use Disorder Treatment Is Associated With Decreased Mortality
- Opioid-free anesthesia : Wrong track or meaningful exit from the era of opioid-based analgesia?
- Suicidal thoughts and behaviors among untreated illicit substance users: a population-based study
- Suicidal thoughts and behaviors among untreated illicit substance users: a population-based study
- Neuropsychiatric Effects Associated with Opioid-Based Management for Palliative Care Patients
- FDA Issues Warning About 'Gas Station Heroin'
- An acute phase reaction from zoledronate mimicking symptoms seen in opioid withdrawal: a case report
- Increased anxiolytic effect in aged female rats and increased motoric behavior in aged male rats to acute alcohol administration: Comparison to younger animals
- Predictors of Caregiver Burden in Family Caregivers of Male Patients with Opioid Use Disorders
- Insights into primary care physicians' detection, intervention and management of patients with substance use disorders in Egypt
- Assessment of the effect of gabapentin on blood pressure in cats with and without chronic kidney disease
- Acute nicotine administration reduces the efficacy of punishment in curbing remifentanil consumption in a seeking-taking chain schedule of reinforcement
- 5-HT 2A and 5-HT 2C receptor antagonism differentially modulate reinforcement learning and cognitive flexibility: behavioural and computational evidence
- 5-HT 2A and 5-HT 2C receptor antagonism differentially modulate reinforcement learning and cognitive flexibility: behavioural and computational evidence
- Assessment of the Antinociceptive, Respiratory-Depressant, and Reinforcing Effects of the Low pKa Fluorinated Fentanyl Analogs, FF3 and NFEPP
- The effect of morphine administration on GluN3B NMDA receptor subunit mRNA expression in rat brain
- Evaluation of the effects of pregabalin and dexamethasone coadministration on preemptive multimodal analgesia and anxiety in third molar surgeries: a triple-blind randomized clinical trial
- Evaluation of the effects of pregabalin and dexamethasone coadministration on preemptive multimodal analgesia and anxiety in third molar surgeries: a triple-blind randomized clinical trial
- Quantifying the Lymphatic Transport of Model Therapeutics from the Brain in Rats
- Neuroimaging of opioid effects in humans across conditions of acute administration, chronic pain therapy, and opioid use disorder
- AI Personal Assistants and Sustainability: Risks and Opportunities
- Matthew Terrill: Prevention of future deaths report
- Pharmacodynamic effects following co-administration of cannabinoids and opioids: A scoping review of human experimental studies
- Effects of paternal arachidonic acid supplementation on offspring behavior and hypothalamus inflammation markers in the mouse
- The social-structural contexts of cannabis consumption and harm reduction among young Nigerian women
- Self-reported pain severity and use of cannabis and opioids in persons with HIV in an urban primary care setting in Northern California: A cross-sectional study
- Discriminative stimulus properties of Cannabis sativa terpenes in rats
- A comprehensive update on the ADMET considerations for a2o calcium channel ligand medications for treating restless legs syndrome
- Vinpocetine attenuates methotrexate-induced hippocampal intoxication via Keap-1/Nrf2, NF-κB/AP-1, and apoptotic pathways in rats
Evidence Blueprint
Effects of Gabapentinoids on Heroin-Induced Ventilatory Depression and Reversal by Naloxone
☊ AI-Driven Related Evidence Nodes
(recent articles with at least 5 words in title)
More Evidence
Effects of Gabapentinoids on Heroin-Induced Ventilatory Depression and Reversal by Naloxone
🌐 365 Days
VR Related Evidence Matrix
- The effect of gabapentin and pregabalin on agitation in dementia: Case series of ten patients
- Opioid Overdose: Limitations in Naloxone Reversal of Respiratory Depression and Prevention of Cardiac Arrest
- Fact vs. fiction: naloxone in the treatment of opioid-induced respiratory depression in the current era of synthetic opioids
- Abuse and addiction in gabapentinoid drug users for neuropathic pain
- Drug clustering to anticipate new aspects of drug safety profile: application to gabapentinoids and other voltage-gated calcium channel ligand drugs
- Associations of methadone and buprenorphine-naloxone doses with unregulated opioid use, treatment retention, and adverse events in prescription-type opioid use disorders: Exploratory analyses of the OPTIMA study
- Enhanced heroin analgesic effect in male offspring of sires who self-administered heroin
- Prescription opioid use among people with opioid dependence and concurrent benzodiazepine and gabapentinoid exposure: An analysis of overdose and all-cause mortality
- Blood Oxygenation and Heart Rate Changes after Diamorphine Intravenous Injection during Opioid Agonist Treatment for Outpatients With Heroin Dependence
- Glutamatergic neurons in ventral pallidum modulate heroin addiction via epithalamic innervation in rats
- Cocaine and heroin interact differently with nondrug reinforcers in a choice situation
- Non-fatal overdose risk associated with prescribing opioid agonists concurrently with other medication: Cohort study conducted using linked primary care, secondary care and mortality records
- Enhancing Protective Antibodies against Opioids through Antigen Display on Virus-like Particles
- No evidence of accelerated epigenetic aging among black heroin users: A case vs control analysis
- Exploring racial and secondary substance use differences in route of administration of opioid drugs: Analysis of the 2015-2019 treatment admission data
- Exploring racial and secondary substance use differences in route of administration of opioid drugs: Analysis of the 2015-2019 treatment admission data
- Blood pressure response to extended-release naltrexone in heroin and prescription opioid users and its implications for cardiovascular morbidity
- Preliminary effectiveness of online opioid overdose and naloxone administration training and impact of naloxone possession on opioid use
- National Institute on Drug Abuse Clinical Trials Network Meeting Report: Managing Patients Exposed to Xylazine-Adulterated Opioids in Emergency, Hospital and Addiction Care Settings
- Activation of Epac in the BLA disrupts reconsolidation and attenuates heroin-seeking behaviour
- The sociodemographic profile and the challenges associated with treatment and rehabilitation in female heroin users: A case series from Northeast India
- Cold nociception as a measure of hyperalgesia during spontaneous heroin withdrawal in mice
- Patient opinion and acceptance of emergency department buprenorphine/naloxone to-go home initiation packs
- Dorsal hippocampal astrocytes mediate the development of heroin withdrawal-enhanced fear learning
- Clinical Implications of the Relationship Between Naltrexone Plasma Levels and the Subjective Effects of Heroin in Humans
- The impact of heroin self-administration and environmental enrichment on ventral tegmental CRF1 receptor expression
- Transient Elevation of Plasma Glucocorticoids Supports Psilocybin-Induced Anxiolysis in Mice
- Abnormal cerebral metabolism and metabolic connectivity in individuals with heroin dependence: an integrated resting-state PET/fMRI study in large-scale networks
- Transcriptional signatures of heroin intake and relapse throughout the brain reward circuitry in male mice
- Antineuropathic Pain Management After Orthopedic Surgery: A Systematic Review
- Take-Home Naloxone Access and Use among Older Adults Living with Pain: A Scoping Review
- P-glycoprotein (MDR1/ABCB1) Restricts Brain Penetration of the Main Active Heroin Metabolites 6-monoacetylmorphine (6-MAM) and Morphine in Mice
- Towards adherence monitoring using breath or oral fluid as a matrix in a methadone maintenance treatment program for patients with a chronic heroin use disorder: issues and interpretation of the results
- Kratom use disorder: case reports on successful treatment with home induction of buprenorphine-naloxone
- Quality of life and associated factors of heroin-dependent patients receiving methadone and buprenorphine maintenance treatment
- Inhibition of dorsal raphe GABAergic neurons blocks hyperalgesia during heroin withdrawal
- Genome-wide association study reveals multiple loci for analgesia and opioid consumption behaviors associated with heroin vulnerability in outbred rats
- Second and fourth (2D:4D) digit ratio in heroin and cannabis addicted patients
- What impacts the acceptability of wearable devices that detect opioid overdose in people who use opioids? A qualitative study
- "Naloxone? Not for me!" First cross-assessment by patients and healthcare professionals of the risk of opioid overdose
- Stocking and supplying naloxone: Findings from a representative sample of community pharmacies in Victoria, Australia
- Prescription Opioid Dose Change Prior to Fatal Opioid-Detected Overdose
- µ-Opioid receptor antagonism facilitates the anxiolytic-like effect of oxytocin in mice
- Adult consequences of repeated nicotine and Δ9-tetrahydrocannabinol (THC) vapor inhalation in adolescent rats
- Pharmacogenetics of Biochemically Verified Abstinence in an Opioid Agonist Therapy Randomized Clinical Trial of Methadone and Buprenorphine/Naloxone
- A study protocol for a European, mixed methods, prospective, cohort study of the effectiveness of naloxone administration by community members, in reversing opioid overdose: NalPORS
- Buprenorphine/naloxone micro-induction in a tertiary care hospital: a retrospective cohort analysis
- Adrenal Crisis Masked as Septic Shock in a Patient With Opioid Use Disorder on Buprenorphine
- A Qualitative Inquiry into the Challenges in Overcoming Heroin Addiction Among Chinese Individuals Who Experience Voluntary Rehabilitation
- A descriptive coronial study of heroin toxicity deaths in Australia, 2020-2022: Characteristics, toxicology and survival times
- Racial and Ethnic Differences in Heroin, Methamphetamine, and Cocaine Use, Treatment, and Mortality Trends in 3 National Data Sources-United States, 2010-2019
- Overdose mortality rates for opioids and stimulant drugs are substantially higher in men than in women: state-level analysis
- The association between naloxone claims and proportion of independent vs. chain pharmacies: A longitudinal analysis of naloxone claims in the US
- Emergency Room Utilization and Methamphetamine Overdose Symptoms Among Syringe Services Program Participants in Washington State
- Gabapentin in drugged driving investigations
- Brain-derived neurotrophic factor serum levels as a candidate biomarker for withdrawal in crack heroin dependence
- Guidance on take-home naloxone distribution and use by community overdose responders in Canada
- The association of medical providers' attitudes about naloxone and people with opioid use disorder and their self-reported "low-barrier" treatment practices
- Inverse pattern of GABAergic system impairment in the external versus internal globus pallidus in male heroin addicts
- Injection Drug Use Frequency Before and After Take-Home Naloxone Training
- Feasibility of paying people who use drugs cash to distribute naloxone within their networks
- Prevalence of and Factors Influencing Suicide Ideation, Attempt, and Completion in Heroin Users: A Systematic Review and Meta-Analysis
- Implementation Documentation and Process Assessment of the PharmNet Intervention: Observational Report
- Scaling up overdose education and naloxone distribution in Kentucky: adoption and reach achieved through a "hub with many spokes" model